Summary. X-ray studies on semi-synthetic human insulin have shown that it crystallizes in the rhombohedral space group R3 and is nearly isomorphous with 2 Zn pig insulin. Precession photographs of crystals of human and pig insulins show observable changes in the intensity patterns. Crystallographic analysis and refinement of semi-synthetic human insulin at 1.9 A resolution have shown that its molecular structure is very like that of pig insulin except at the C-terminus of the B chain where the change in sequence occurs. We also report the results of a high resolution crystallographic study of human insulins from different origins. The X-ray diffraction patterns of three non-pancreatic human insulins are indistinguishable from each other and from pancreatic human insulin. Refinement of the structures of the non-pancreatic human insulins has shown that they are identical within the limits of experimental error.
Insulin with the exact chemical structure of the human hormone has been made available recently for the treatment of diabetes. The human insulins were manufactured by quite different methods (semi-synthetically, by chemical modification of pig insulin [1] , and biosynthetically, by recombinant DNA technology [12, 13] . It has been demonstrated that the human insulins produced by these very different preparative pathways are analytically and biochemically indistinguishable [10] . The production of human insulin by recombinant DNA techniques is therefore established and will in the future have an immense impact on the patterns of insulin manufacture.
Human insulin differs from the pig insulin sequence only at the C-terminal B chain residue which in pig insulin is alanine and in human insulin threonine. We report here the 2 Zn insulin crystal structure of human insulin prepared by semi-synthetic methods (Novo) [1] and compare it with the accurately known pig 2 Zn insulin crystal structure [3] . A comparison between human 2 Zn insulin crystals from pancreatic and non-pancreatic sources is given also in this study.
* The determination of the human (semi-synthetic) 2 Zn insulin structure was carried out at the University of York. The part of the paper in which the human 2 Zn insulin crystal structures from different origins are compared was carried out at Birkbeck College (London) and the University of York.
Comparison between the human and pig 2 Zn insulin crystal structures reveals that the different sequence at B30 has altered the hormone's conformation only at B29 and B30. These small but distinct changes, however, affect the interactions between the hexamers in the crystal.
It was thought desirable to investigate the 2 Zn insulin crystal structures of the differently prepared human insulins. Crystal formation requires not only the proper folding and assembly of the constituent molecules but also that they make, with exact repetition, very specific and delicate contacts. Thus the structural identity of crystals is a sensitive test of the molecule's structural integrity. The technique also demonstrates whether or not the crystal packing has been perturbed in specimens of different origin, thus helping to ensure that the different crystals have identical physical properties. The study also provided a useful opportunity to assess protein refinement procedures [14] .
Materials and Methods
Rhombohedral 2-zinc insulin crystals were grown using the batch crystallization method of Schlichtkrull [2] for human insulin samples prepared by enzymatic modification of pig insulin (Novo), by bacterial production of the separate A and B chains from their synthetic genes (Lilly), by conversion of proinsulin produced from micro- organisms (Lilly), and from the human pancreas. Insulin crystals were mounted in sealed capillary tubes containing a few drops of mother liquor. Three-dimensional X-ray diffraction data to 1.9 A resolution were collected using CuKa radiation on a four-circle diffractometer (Hilger & Watts, London, UK) controlled by a PDP-I1 computer (Digital, Maynard, USA). The data were collected with an co-scan technique with 30-40 steps of 0.03 ~ and step times of 1-4s. Radiation damage and crystal alignment were monitored by measuring the intensities of three standard reflections after every 100 reflections. Intensities were corrected for background, Lorentz and polarization effects and semi-empirical absorption corrections were applied [4] .
X-ray diffraction patterns of the hkiO projections of four types of human insulin were recorded photographically using a precession camera (Nonius, Delft, The Netherlands). X-ray reflections to 1.9 A resolution from the other non-pancreatic human insulin crystals were measured automatically on a computer-controlled four-circle Hilger Watts diffractometer using CuKa radiation. The reflections were corrected for background, Lorentz and polarization effects, and for absorption using the semi-empirical method [4] .
Results
Crystal data for both human (Novo) and pig 2 Zn insulin are given in Table 1 . There are distinct changes in the intensity patterns observed between human (Novo) and pig insulins (Fig.l) . X-ray diffraction patterns of the hkiO projections of four types of h u m a n insulin were found to be indistinguishable (Fig. 2) .
The difference Fourier technique has been widely applied in the study of protein structures [11] , since it provides a sensitive monitor of conformational changes and is useful for detecting errors in atomic positions.
An initial difference Fourier map was calculated for the Novo human insulin with coefficients (IFhu~anl -IFcalcl) and phases acalc, where IFhumanl is the observed structure amplitude for human insulin and [Fcalc [ and acalc are the calculated structure amplitudes and phases derived from the pig 2 Zn insulin crystal cell. The residues B28-B30 were excluded from the calculation of I Fcalcl and the phase a calc, since significant differences in their atomic positions arising from the sequence change at B 30 were possible. This map revealed the positions of the threonine atoms at B 30 and indicated some distinct shifts in the B 30 carboxyl groups. Changes in the water structure in the region of B 28-B 30 were observed also.
The new atomic coordinates for the B 30 threonine side chain and C-terminal carboxyl group for both molecules in the asymmetric unit, together with the coordinates of the rest of the molecule and solvent (obtained by placing the pig 2 Zn insulin coordinates in the human 2 Zn insulin cell) were then refined crystallographically using the fast Fourier least-squares method [5, 61. After convergence of the least squares refinement, a further difference Fourier map was calculated using as coefficients (IFhumanl -IFol) and, as phases ac, where IFol and ac are the calculated structure amplitudes and phases determined from the refined human insulin coordinates, excluding the residues B28-B30 and some of the surrounding solvent molecules. Improved atomic coordinates for some atoms were obtained from this difference map and further least-squares refinement cycles were carried out. Figure 3 a R= (271Fo I _ IFcI)/~IFcl (see Table 1 )
Fast Fourier least-squares refinement calculations [5, 6] were then undertaken for these human insulins, with a starting model derived from the pig 2 Zn insulin coordinates and the new atomic coordinates for the B 30 threonine side chain and carboxyl group obtained from the initial difference maps. After convergence, a difference Fourier map was calculated in the region of B 28-B 30 and the surrounding solvent. Examples of the difference electron density for B 29 and B 30 for each of the insulins is shown in Figure 5 .
Details of the refinement of the three non-pancreatic human 2 Zn insulin crystals are given in Table 2 .
The refined coordinates for the three human insulins have been compared and the differences between (Table 3) . Equivalent protein atoms in the three crystal structures did not vary by more than two standard deviations and therefore we conclude that within these limits all three structures are identical.
Discussion
The differences between the human (Novo) and pig insulin structures are considerably smaller than those found between the two molecules of the 2 Zn pig insulin dimer [3] . The major points of interest are that in human insulin the conformation of the B 29 lysine side chain is better defined for both molecules. In molecule I the lysine has a similar conformation to that found in pig insulin whereas in molecule II the lysine has one major conformation which is different from both conformations seen in pig insulin for this side chain. The main chain atoms of B 30 of both molecules have been shifted significantly at the carboxyl groups. Some changes in the solvent structure in the region of B28-B30 are observed also, notably around B29 N and B30 O. The B29 and B 30 residues make a number of interactions in the crystal; the change in sequence at B 30 in human insulin has produced some alterations in the intermolecular contacts. The extra H-bonding capacity of the threonine residue at B 30 in human insulin and the altered contacts between the hexamers in the 2 Zn insulin crystals may well have some bearing on the observation that the human 2 Zn insulin crystals attract water more noticeably than the pig 2 Zn insulin crystals in the capillary tubes.
This analysis confirms that although there are considerable differences in the X-ray diffraction patterns of human and pig 2Zn insulin (Fig.l) the change at B30 has not significantly affected their 3-dimensional structures. The small but possibly real differences in metabolic behaviour reported with human insulin [7] [8] [9] [10] are consistent with slightly enhanced solubility and more rapid absorption. Further biological and clinical studies are needed, however, to determine this.
